Haleon Begins Inhouse Production of Panadol
Summary
Haleon Pakistan starts manufacturing Panadol 500mg at Jamshoro facility, enhancing production capacity.
Kind of disclosure: Expansion/Capex
Read the original filingKey facts
- Commencement of inhouse manufacturing
- Panadol 500mg tablets
- New facility in Jamshoro
- Manufacturing started
- Investment in Jamshoro facility
- Announced 2023-10-13
Haleon Pakistan Limited (HALEON) on Nafa
Last price Rs 692.00 · Pharmaceuticals · You can own HALEON shares from your phone.
More HALEON announcements
- NoticeChange of Name of External Auditors
- NoticeTransmission of Quarterly Report for the Period Ended 30 September 2026
- Financial resultHaleon Pakistan Limited reported a stable performance for the nine months ended September 30, 2026Filed as: Financial Results for the Quarter Ended 30 September 2026
- NoticeNotice of Board of Directors Meeting - (Q3-2026)
- NoticeCredit of Interim Cash Dividend
- NoticePrior Publication of Notice of Credit of Interim Cash Dividend
Source: Haleon Pakistan Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.